These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9846012)

  • 1. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group.
    Ueda T; Miyawaki S; Asou N; Kuraishi Y; Hiraoka A; Kuriyama K; Minami S; Ohshima T; Ino T; Tamura J; Kanamaru A; Nishikawa K; Tanimoto M; Oh H; Saito K; Nagata K; Naoe T; Yamada O; Urasaki Y; Sakura T; Ohno R
    Int J Hematol; 1998 Oct; 68(3):279-89. PubMed ID: 9846012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).
    Tanimoto M; Miyawaki S; Ino T; Kyo T; Sakamaki H; Naoe T; Hiraoka A; Asou N; Ohshima T; Tsubaki K; Kuriyama K; Ueda T; Minamil S; Okabe K; Saito H; Murakami H; Hirano M; Dohy H; Onozawa Y; Suzuki H; Ohno R
    Int J Hematol; 1998 Dec; 68(4):421-9. PubMed ID: 9885441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.
    Takeuchi J; Kyo T; Naito K; Sao H; Takahashi M; Miyawaki S; Kuriyama K; Ohtake S; Yagasaki F; Murakami H; Asou N; Ino T; Okamoto T; Usui N; Nishimura M; Shinagawa K; Fukushima T; Taguchi H; Morii T; Mizuta S; Akiyama H; Nakamura Y; Ohshima T; Ohno R
    Leukemia; 2002 Jul; 16(7):1259-66. PubMed ID: 12094249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
    Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
    Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
    Ohno R; Kobayashi T; Tanimoto M; Hiraoka A; Imai K; Asou N; Tomonaga M; Tsubaki K; Takahashi I; Kodera Y
    Cancer; 1993 Jun; 71(12):3888-95. PubMed ID: 8508355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study.
    Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Pagnucco G; Resegotti L; Locatelli F; Ficarra F; Bacigalupo A; Carella AM
    Leukemia; 1992; 6 Suppl 2():204-8. PubMed ID: 1578935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S
    Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.
    Fière D; Lepage E; Sebban C; Boucheix C; Gisselbrecht C; Vernant JP; Varet B; Broustet A; Cahn JY; Rigal-Huguet F
    J Clin Oncol; 1993 Oct; 11(10):1990-2001. PubMed ID: 8410124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia.
    Bassan R; Lerede T; Di Bona E; Rambaldi A; Rossi G; Pogliani E; Oriani A; D'Emilio A; Izzi T; Lambertenghi-Deliliers G; Corneo G; Barbui T
    Br J Haematol; 1999 Mar; 104(4):755-62. PubMed ID: 10192437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.
    Morel P; Lepage E; Brice P; Dupriez B; D'Agay MF; Fenaux P; Gosselin B; Bauters F; Gisselbrecht C
    J Clin Oncol; 1992 Jul; 10(7):1078-85. PubMed ID: 1607914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.
    Dekker AW; van't Veer MB; Sizoo W; Haak HL; van der Lelie J; Ossenkoppele G; Huijgens PC; Schouten HC; Sonneveld P; Willemze R; Verdonck LF; van Putten WL; Löwenberg B
    J Clin Oncol; 1997 Feb; 15(2):476-82. PubMed ID: 9053468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG).
    Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Sakamaki H; Tsubaki K; Saito K; Ohno R
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S30-5. PubMed ID: 9272131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase].
    Wernli M; Gratwohl A; von Fliedner V; Tichelli A; Clément F; Grob JP; Chapuis B; Maurice P; Brun del Re G; Fey MF
    Schweiz Med Wochenschr; 1991 Feb; 121(6):194-8. PubMed ID: 2008599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
    Li J; Zhang ZB; Liu ZR; Yang M; Nie YX; Wu MM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.